A PHASE 1, OPEN-LABEL, 2-PERIOD, FIXED-SEQUENCE STUDY TO ESTIMATE THE EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS OF PF-07258669 IN OLDER ADULT PARTICIPANTS
Latest Information Update: 22 Jan 2025
Price :
$35 *
At a glance
- Drugs Itraconazole (Primary) ; PF 07258669 (Primary)
- Indications Anorexia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 16 Jan 2025 Planned End Date changed from 11 Feb 2025 to 26 Feb 2025.
- 16 Jan 2025 Planned primary completion date changed from 11 Feb 2025 to 24 Jan 2025.
- 16 Jan 2025 Status changed from not yet recruiting to recruiting.